^*Springs Aesthetics, Colorado Springs, CO, Colorado, U.S.A.

^†Orbital & Oculofacial Plastic Surgery, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.

^‡TOC Eye and Face, Austin, TX Department of Ophthalmology, Dell Medical School, The University of Texas at Austin, Texas, U.S.A.

^§Jules Stein Eye Institute, UCLA, Los Angeles, California, U.S.A.

^∥W Cosmetic Surgery, Plymouth Meeting, Pennsylvania, U.S.A.

^¶Chief Oculofacial Surgery, Duke University Medical Center, Durham, North Carolina, U.S.A.

Accepted for publication January 24, 2023.

T.N. is shareholder of AVYA Skincare, Inc. and J.W. Allergan, Galderma, Lutronic, Prollenium, Merz, Revance, SkinCeuticals, Tarsus, Stroma Medical.Other authors have no financial or conflicts of interest to disclose.s

Address correspondence and reprint requests to Julie Woodward, M.D., Duke Eye Center South Durham, 234 Crooked Creek Rd., Durham, NC 27613. E-mail: [email protected]